A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Johnson & Johnson is set to issue a report next month outlining how much it has raised US prices for its prescription drugs.

Valeant Pharmaceuticals is reorganizing into three segments and maintained its earnings forecast for the full year.

And so, another working week will soon draw to a close. So go ahead, start daydreaming about weekend plans. We have already started doing so and look forward to spending time with our short and ...

After a brief, but rewarding stay here at The Wall Street Journal, we are taking our Pharmalot act to a different theater.

On Monday, Pharmalot's Ed Silverman shocked the pharmaceutical business by returning from vacation and announcing that his blog was no more. Over the past two years, Pharmalot grew into the ...

Former Star-Ledger pharmaceuticals reporter Ed Silverman is considering reviving his blog, Pharmalot. He is now the legal owner of "Pharmalot.com" and is keeping the brand alive in the form of a ...

Goodbye, Pharmalot The popular blog covering pharmaceutical and biotech industry news has been shuttered.